RMTI
Rockwell Medical IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$37.01M
P/E Ratio
—
EPS
$-0.15
Beta
1.71
52W High
$2.10
52W Low
$0.78
50-Day MA
$0.99
200-Day MA
$1.07
Dividend Yield
—
Profit Margin
-7.67%
Forward P/E
33.00
PEG Ratio
4.43
About Rockwell Medical Inc
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.
Fundamentals
| Revenue (TTM) | $69.26M |
| Gross Profit (TTM) | $11.70M |
| EBITDA | $-2.50M |
| Operating Margin | -2.17% |
| Return on Equity | -15.30% |
| Return on Assets | -5.04% |
| Revenue/Share (TTM) | $1.93 |
| Book Value | $0.94 |
| Price-to-Book | 1.03 |
| Price-to-Sales (TTM) | 0.53 |
| EV/Revenue | 0.368 |
| EV/EBITDA | 22.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -25.60% |
| Shares Outstanding | $39.41M |
| Float | $35.20M |
| % Insiders | 12.60% |
| % Institutions | 8.92% |
Analyst Ratings
Consensus ($3.00 target)
1
Strong Buy1
BuyData last updated: 4/9/2026